25 XP   0   0   10

Verastem Inc
Buy, Hold or Sell?

Let's analyse Verastem together

PenkeI guess you are interested in Verastem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Verastem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Verastem Inc

I send you an email if I find something interesting about Verastem Inc.

Quick analysis of Verastem (30 sec.)










What can you expect buying and holding a share of Verastem? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.93
Expected worth in 1 year
$3.99
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$1.06
Return On Investment
8.9%

For what price can you sell your share?

Current Price per Share
$11.80
Expected price per share
$9.78 - $14.22
How sure are you?
50%

1. Valuation of Verastem (5 min.)




Live pricePrice per Share (EOD)

$11.80

Intrinsic Value Per Share

$-67.40 - $-35.54

Total Value Per Share

$-64.47 - $-32.61

2. Growth of Verastem (5 min.)




Is Verastem growing?

Current yearPrevious yearGrowGrow %
How rich?$78.5m$59.2m$30.7m34.2%

How much money is Verastem making?

Current yearPrevious yearGrowGrow %
Making money-$21.1m-$18.4m-$2.6m-12.6%
Net Profit Margin0.0%-325.4%--

How much money comes from the company's main activities?

3. Financial Health of Verastem (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#423 / 1031

Most Revenue
#826 / 1031

Most Profit
#742 / 1031

Most Efficient
#279 / 1031

What can you expect buying and holding a share of Verastem? (5 min.)

Welcome investor! Verastem's management wants to use your money to grow the business. In return you get a share of Verastem.

What can you expect buying and holding a share of Verastem?

First you should know what it really means to hold a share of Verastem. And how you can make/lose money.

Speculation

The Price per Share of Verastem is $11.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Verastem.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Verastem, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.93. Based on the TTM, the Book Value Change Per Share is $0.26 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Verastem.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.02-8.7%-0.84-7.1%-0.73-6.2%-0.88-7.5%-0.73-6.2%
Usd Book Value Change Per Share-0.97-8.2%0.262.2%-0.40-3.4%-0.10-0.8%-0.04-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.97-8.2%0.262.2%-0.40-3.4%-0.10-0.8%-0.04-0.4%
Usd Price Per Share8.14-6.03-0.96-2.72-3.78-
Price to Earnings Ratio-1.99--1.71--0.33--0.73--1.42-
Price-to-Total Gains Ratio-8.43--3.16--0.56--1.78--133.18-
Price to Book Ratio2.78-1.65-0.40-1.04-1.21-
Price-to-Total Gains Ratio-8.43--3.16--0.56--1.78--133.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.8
Number of shares84
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.26-0.10
Usd Total Gains Per Share0.26-0.10
Gains per Quarter (84 shares)22.18-8.33
Gains per Year (84 shares)88.70-33.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1089790-33-43
201771680-67-76
302662570-100-109
403553460-133-142
504444350-167-175
605325240-200-208
706216130-233-241
807107020-267-274
907987910-300-307
1008878800-333-340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.049.00.02.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.014.00.030.0%10.030.00.025.0%13.037.00.026.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.050.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%6.014.00.030.0%10.030.00.025.0%13.037.00.026.0%

Fundamentals of Verastem

About Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase pathway which is involved in cell proliferation, migration, transformation, and survival of tumor cells; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors. The company is involved in clinical studies, including RAMP 301, a randomized global confirmatory trial to evaluate the combination of Avutometinib and Defactinib for the treatment of patients with recurrent low-grade serous ovarian cancer; RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of Avutometinib and in combination with Defactinib; and FRAME, an investigation of Avutometinib and Defactinib in patients with KRAS mutant cancers and subsequent analyses; and RAMP 204 and 205. It has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing Avutometinib; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic, and prophylactic uses in humans. In addition, it has a clinical collaboration agreement with Amgen, Inc. to evaluate the combination of Avutometinib with Amgen's KRAS-G12C inhibitor LUMAKRAS which in Phase 1/2 trial entitled RAMP 203; and a discovery and development collaboration with GenFleet Therapeutics to advance new programs targeting RAS pathway-driven cancers. Verastem, Inc. was incorporated in 2010 and is headquartered in Needham, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-22 07:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Verastem Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Verastem earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-325.4%+325.4%
TTM-5Y-57,936.3%+57,936.3%
5Y-57,936.3%10Y-28,999.7%-28,936.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY-325.4%-263.0%-62.4%
5Y-57,936.3%-452.4%-57,483.9%
10Y-28,999.7%-589.0%-28,410.7%
1.1.2. Return on Assets

Shows how efficient Verastem is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -18.3% Return on Assets means that Verastem generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Verastem Inc:

  • The MRQ is -18.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-13.2%-5.0%
TTM-13.2%YOY-17.6%+4.4%
TTM-13.2%5Y-14.9%+1.6%
5Y-14.9%10Y-14.7%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.3%-12.5%-5.8%
TTM-13.2%-12.2%-1.0%
YOY-17.6%-11.2%-6.4%
5Y-14.9%-13.3%-1.6%
10Y-14.7%-14.6%-0.1%
1.1.3. Return on Equity

Shows how efficient Verastem is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • -34.8% Return on Equity means Verastem generated $-0.35 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Verastem Inc:

  • The MRQ is -34.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.8%TTM-24.4%-10.5%
TTM-24.4%YOY-32.1%+7.7%
TTM-24.4%5Y-58.5%+34.1%
5Y-58.5%10Y-38.9%-19.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.8%-16.0%-18.8%
TTM-24.4%-15.8%-8.6%
YOY-32.1%-13.9%-18.2%
5Y-58.5%-18.2%-40.3%
10Y-38.9%-19.1%-19.8%

1.2. Operating Efficiency of Verastem Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Verastem is operating .

  • Measures how much profit Verastem makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Verastem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-325.8%+325.8%
TTM-5Y-37,894.8%+37,894.8%
5Y-37,894.8%10Y-18,970.5%-18,924.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY-325.8%-280.2%-45.6%
5Y-37,894.8%-459.9%-37,434.9%
10Y-18,970.5%-596.9%-18,373.6%
1.2.2. Operating Ratio

Measures how efficient Verastem is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Verastem Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.510-3.510
TTM-5Y380.719-380.719
5Y380.71910Y191.291+189.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY3.5103.609-0.099
5Y380.7195.554+375.165
10Y191.2917.396+183.895

1.3. Liquidity of Verastem Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Verastem is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.45 means the company has $5.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Verastem Inc:

  • The MRQ is 5.447. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.808. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.447TTM6.808-1.361
TTM6.808YOY5.212+1.595
TTM6.8085Y6.396+0.412
5Y6.39610Y8.089-1.693
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4473.987+1.460
TTM6.8084.440+2.368
YOY5.2125.569-0.357
5Y6.3966.158+0.238
10Y8.0896.492+1.597
1.3.2. Quick Ratio

Measures if Verastem is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Quick Ratio of 7.48 means the company can pay off $7.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Verastem Inc:

  • The MRQ is 7.480. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.954. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.480TTM7.954-0.474
TTM7.954YOY6.696+1.257
TTM7.9545Y8.677-0.723
5Y8.67710Y12.271-3.594
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4803.653+3.827
TTM7.9544.158+3.796
YOY6.6965.515+1.181
5Y8.6776.012+2.665
10Y12.2716.206+6.065

1.4. Solvency of Verastem Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Verastem assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Verastem to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that Verastem assets are financed with 47.5% credit (debt) and the remaining percentage (100% - 47.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Verastem Inc:

  • The MRQ is 0.475. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.449. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.475TTM0.449+0.027
TTM0.449YOY0.443+0.006
TTM0.4495Y0.459-0.011
5Y0.45910Y0.325+0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4750.336+0.139
TTM0.4490.330+0.119
YOY0.4430.267+0.176
5Y0.4590.367+0.092
10Y0.3250.378-0.053
1.4.2. Debt to Equity Ratio

Measures if Verastem is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Verastem to the Biotechnology industry mean.
  • A Debt to Equity ratio of 90.6% means that company has $0.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Verastem Inc:

  • The MRQ is 0.906. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.847. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.906TTM0.847+0.059
TTM0.847YOY0.808+0.039
TTM0.8475Y2.128-1.281
5Y2.12810Y1.209+0.919
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9060.376+0.530
TTM0.8470.398+0.449
YOY0.8080.334+0.474
5Y2.1280.431+1.697
10Y1.2090.476+0.733

2. Market Valuation of Verastem Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Verastem generates.

  • Above 15 is considered overpriced but always compare Verastem to the Biotechnology industry mean.
  • A PE ratio of -1.99 means the investor is paying $-1.99 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Verastem Inc:

  • The EOD is -2.890. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.993. Based on the earnings, the company is expensive. -2
  • The TTM is -1.705. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.890MRQ-1.993-0.896
MRQ-1.993TTM-1.705-0.288
TTM-1.705YOY-0.327-1.378
TTM-1.7055Y-0.726-0.979
5Y-0.72610Y-1.422+0.695
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.890-2.697-0.193
MRQ-1.993-2.422+0.429
TTM-1.705-2.709+1.004
YOY-0.327-4.116+3.789
5Y-0.726-6.257+5.531
10Y-1.422-6.478+5.056
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Verastem Inc:

  • The EOD is -2.664. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.838. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.903. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.664MRQ-1.838-0.826
MRQ-1.838TTM-1.903+0.065
TTM-1.903YOY-0.387-1.516
TTM-1.9035Y-1.154-0.749
5Y-1.15410Y-1.915+0.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.664-3.344+0.680
MRQ-1.838-2.939+1.101
TTM-1.903-3.486+1.583
YOY-0.387-5.592+5.205
5Y-1.154-8.464+7.310
10Y-1.915-8.872+6.957
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Verastem is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.78 means the investor is paying $2.78 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Verastem Inc:

  • The EOD is 4.028. Based on the equity, the company is fair priced.
  • The MRQ is 2.779. Based on the equity, the company is underpriced. +1
  • The TTM is 1.648. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.028MRQ2.779+1.249
MRQ2.779TTM1.648+1.130
TTM1.648YOY0.398+1.250
TTM1.6485Y1.038+0.610
5Y1.03810Y1.212-0.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.0282.198+1.830
MRQ2.7792.042+0.737
TTM1.6482.121-0.473
YOY0.3982.907-2.509
5Y1.0383.682-2.644
10Y1.2124.114-2.902
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Verastem Inc.

3.1. Institutions holding Verastem Inc

Institutions are holding 66.794% of the shares of Verastem Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Viking Global Investors LP9.72090.0732245629200
2023-09-30Bvf Inc6.66940.3695168521900
2023-12-31Vivo Capital, LLC6.08851.0254153846100
2023-09-30Deerfield Management Co6.08850.2756153846100
2023-12-31Orbimed Advisors, LLC6.05160.2486152911500
2023-12-31Soleus Capital Management, L.P.5.6421.28761425634782655.8087
2023-12-31Adage Capital Partners Gp LLC5.14480.0219130000000
2023-12-31Vanguard Group Inc4.55220.0002115025300
2023-09-30Citadel Advisors Llc3.53720.0016893785-35655-3.8362
2023-09-30TANG CAPITAL MANAGEMENT LLC3.52821.0227891514-248486-21.797
2023-12-31BlackRock Inc1.29220.0001326512242178.011
2023-12-31Longwood Capital Partners LLC0.91911.064223224922490.9778
2023-12-31Geode Capital Management, LLC0.91870.0002232128122135.5535
2023-12-31Opaleye Management Inc0.83660.457621140000
2023-12-31Sectoral Asset Management Inc0.80470.712720332700
2023-12-31Vontobel Holding Ltd.0.80470.008320332700
2023-12-31Susquehanna International Group, LLP0.64240.0003162312140042628.837
2023-12-31Jefferies Financial Group Inc0.63140.008515954100
2023-12-31AlphaCentric Advisors, LLC0.59360.819615000000
2023-12-31Morgan Stanley - Brokerage Accounts0.56830.00011436001324611189.1642
Total 65.0357.397916433130+105306+0.6%

3.2. Funds holding Verastem Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.9940.000675692500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.42640.004436060800
2023-12-31AlphaCentric LifeSci Healthcare I0.59331.171415000000
2024-01-31Fidelity Extended Market Index0.51710.004313073000
2023-09-30BlackRock Extended Mkt Composite0.2270.0033573892651985.9054
2023-12-31BlackRock Extended Equity Market K0.1980.00350067-101-0.2013
2024-01-31Fidelity Total Market Index0.16680.000642160467112.4597
2024-01-31Fidelity Series Total Market Index0.12470.00063151727649.6129
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08930.00292257500
2023-12-31Northern Trust Extended Eq Market Idx0.08160.00292063900
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08160.00292063900
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.08020.000520279-453250-95.7175
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.08020.00082027900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07170.002918131340.1879
2024-02-29Vanguard Balanced Index Inv0.06640.00041678000
2024-01-31Spartan Total Market Index Pool E0.0570.00061440700
2024-01-31Fidelity Nasdaq Composite Index0.05310.00111341700
2023-12-31CornerCap Small-Cap Value Advisor0.04670.07241181000
2023-12-31CornerCap Fundametrics Small0.04670.07231181000
2023-12-31SSgA U.S. Extended Market Index Class I0.03810.00299631410074.1276
Total 7.03991.35081779793-415263-23.3%

3.3. Insider Transactions

Insiders are holding 0.554% of the shares of Verastem Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-20Daniel CalkinsSELL5511.07
2024-03-18Dan PatersonSELL24410.71
2024-03-18Robert E GagnonSELL28310.71
2024-01-12Robert E GagnonSELL920410.95
2024-01-05Daniel CalkinsSELL68.5
2023-12-26Daniel CalkinsSELL258.08
2023-12-20Daniel CalkinsSELL577.93
2023-12-18Dan PatersonSELL2447.64
2023-12-18Robert E GagnonSELL2847.64
2023-10-05Daniel CalkinsSELL57.3
2023-09-25Daniel CalkinsSELL259.4
2023-09-21Daniel CalkinsSELL2329.31
2023-09-18Dan PatersonSELL2409.91
2023-09-18Robert E GagnonSELL2789.91
2023-07-06Daniel CalkinsSELL58.02
2023-06-26Daniel CalkinsSELL268.17
2023-06-20Brian M StuglikSELL27510.3
2023-06-20Dan PatersonSELL18310.3
2023-06-20Robert E GagnonSELL13010.3
2023-06-16Brian M StuglikSELL4879.92

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Verastem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.9650.264-466%-0.397-59%-0.099-90%-0.043-96%
Book Value Per Share--2.9293.455-15%2.342+25%3.181-8%3.372-13%
Current Ratio--5.4476.808-20%5.212+4%6.396-15%8.089-33%
Debt To Asset Ratio--0.4750.449+6%0.443+7%0.459+4%0.325+46%
Debt To Equity Ratio--0.9060.847+7%0.808+12%2.128-57%1.209-25%
Dividend Per Share----0%-0%-0%-0%
Eps---1.021-0.837-18%-0.729-29%-0.883-14%-0.726-29%
Free Cash Flow Per Share---1.107-0.829-25%-0.629-43%-0.699-37%-0.616-44%
Free Cash Flow To Equity Per Share---1.1240.498-326%0.787-243%-0.004-100%0.123-1013%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---35.539--------
Intrinsic Value_10Y_min---67.404--------
Intrinsic Value_1Y_max---2.628--------
Intrinsic Value_1Y_min---3.370--------
Intrinsic Value_3Y_max---8.608--------
Intrinsic Value_3Y_min---13.117--------
Intrinsic Value_5Y_max---15.445--------
Intrinsic Value_5Y_min---26.067--------
Market Cap298486900.000+27%218217120.000158680257.900+38%24173012.188+803%69948066.268+212%96119580.509+127%
Net Profit Margin----0%-3.2540%-579.3630%-289.9970%
Operating Margin----0%-3.2580%-378.9480%-189.7050%
Operating Ratio----0%3.510-100%380.719-100%191.291-100%
Pb Ratio4.028+31%2.7791.648+69%0.398+598%1.038+168%1.212+129%
Pe Ratio-2.890-45%-1.993-1.705-14%-0.327-84%-0.726-64%-1.422-29%
Price Per Share11.800+31%8.1406.031+35%0.956+752%2.717+200%3.776+116%
Price To Free Cash Flow Ratio-2.664-45%-1.838-1.903+4%-0.387-79%-1.154-37%-1.915+4%
Price To Total Gains Ratio-12.225-45%-8.433-3.157-63%-0.557-93%-1.781-79%-133.183+1479%
Quick Ratio--7.4807.954-6%6.696+12%8.677-14%12.271-39%
Return On Assets---0.183-0.132-28%-0.176-4%-0.149-19%-0.147-20%
Return On Equity---0.348-0.244-30%-0.321-8%-0.585+68%-0.389+12%
Total Gains Per Share---0.9650.264-466%-0.397-59%-0.099-90%-0.043-96%
Usd Book Value--78533000.00089951500.000-13%59231750.000+33%80981100.000-3%85551350.000-8%
Usd Book Value Change Per Share---0.9650.264-466%-0.397-59%-0.099-90%-0.043-96%
Usd Book Value Per Share--2.9293.455-15%2.342+25%3.181-8%3.372-13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.021-0.837-18%-0.729-29%-0.883-14%-0.726-29%
Usd Free Cash Flow---29681000.000-21615000.000-27%-15918250.000-46%-17820200.000-40%-15659000.000-47%
Usd Free Cash Flow Per Share---1.107-0.829-25%-0.629-43%-0.699-37%-0.616-44%
Usd Free Cash Flow To Equity Per Share---1.1240.498-326%0.787-243%-0.004-100%0.123-1013%
Usd Market Cap298486900.000+27%218217120.000158680257.900+38%24173012.188+803%69948066.268+212%96119580.509+127%
Usd Price Per Share11.800+31%8.1406.031+35%0.956+752%2.717+200%3.776+116%
Usd Profit---27368000.000-21126500.000-23%-18462000.000-33%-22324450.000-18%-18359875.000-33%
Usd Revenue----0%1298000.000-100%5660800.000-100%3498350.000-100%
Usd Total Gains Per Share---0.9650.264-466%-0.397-59%-0.099-90%-0.043-96%
 EOD+5 -3MRQTTM+4 -25YOY+11 -205Y+8 -2310Y+8 -23

4.2. Fundamental Score

Let's check the fundamental score of Verastem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.890
Price to Book Ratio (EOD)Between0-14.028
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.480
Current Ratio (MRQ)Greater than15.447
Debt to Asset Ratio (MRQ)Less than10.475
Debt to Equity Ratio (MRQ)Less than10.906
Return on Equity (MRQ)Greater than0.15-0.348
Return on Assets (MRQ)Greater than0.05-0.183
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Verastem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.204
Ma 20Greater thanMa 5011.656
Ma 50Greater thanMa 10011.958
Ma 100Greater thanMa 2009.826
OpenGreater thanClose11.790
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets149,718
Total Liabilities71,185
Total Stockholder Equity78,533
 As reported
Total Liabilities 71,185
Total Stockholder Equity+ 78,533
Total Assets = 149,718

Assets

Total Assets149,718
Total Current Assets143,682
Long-term Assets6,036
Total Current Assets
Cash And Cash Equivalents 78,835
Short-term Investments 59,220
Net Receivables 42
Other Current Assets 5,585
Total Current Assets  (as reported)143,682
Total Current Assets  (calculated)143,682
+/-0
Long-term Assets
Property Plant Equipment 1,208
Long-term Assets Other 4,587
Long-term Assets  (as reported)6,036
Long-term Assets  (calculated)5,795
+/- 241

Liabilities & Shareholders' Equity

Total Current Liabilities26,380
Long-term Liabilities44,805
Total Stockholder Equity78,533
Total Current Liabilities
Short-term Debt 941
Accounts payable 7,184
Other Current Liabilities 17,928
Total Current Liabilities  (as reported)26,380
Total Current Liabilities  (calculated)26,053
+/- 327
Long-term Liabilities
Long term Debt 40,086
Capital Lease Obligations 1,471
Long-term Liabilities  (as reported)44,805
Long-term Liabilities  (calculated)41,557
+/- 3,248
Total Stockholder Equity
Common Stock3
Retained Earnings -824,890
Accumulated Other Comprehensive Income 13
Other Stockholders Equity 882,248
Total Stockholder Equity (as reported)78,533
Total Stockholder Equity (calculated)57,374
+/- 21,159
Other
Capital Stock3
Cash and Short Term Investments 138,055
Common Stock Shares Outstanding 26,808
Current Deferred Revenue327
Liabilities and Stockholders Equity 149,718
Net Debt -37,278
Net Invested Capital 97,460
Net Working Capital 117,302
Property Plant and Equipment Gross 2,800
Short Long Term Debt Total 41,557



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-31
> Total Assets 
3,604
0
0
62,767
59,037
110,705
105,664
98,830
92,923
86,241
79,961
132,429
125,261
115,726
107,342
97,883
98,649
142,003
135,696
123,666
113,094
102,564
95,423
89,044
83,629
76,249
61,839
63,139
89,791
68,411
172,918
183,155
277,236
243,365
218,541
192,600
145,046
208,154
198,532
217,770
154,349
136,901
123,890
111,877
108,662
116,148
100,409
111,095
95,050
120,877
191,758
176,153
149,718
149,718176,153191,758120,87795,050111,095100,409116,148108,662111,877123,890136,901154,349217,770198,532208,154145,046192,600218,541243,365277,236183,155172,91868,41189,79163,13961,83976,24983,62989,04495,423102,564113,094123,666135,696142,00398,64997,883107,342115,726125,261132,42979,96186,24192,92398,830105,664110,70559,03762,767003,604
   > Total Current Assets 
0
0
0
61,830
47,941
41,557
39,197
47,281
57,082
67,709
58,292
101,007
101,955
106,585
99,558
94,476
95,316
134,872
132,744
121,181
110,843
100,537
93,533
87,313
81,295
74,005
59,753
61,204
87,787
66,030
170,437
158,729
253,259
216,596
192,346
166,958
84,961
148,646
144,592
188,555
144,938
127,678
114,760
108,757
105,740
113,439
97,875
108,759
92,870
118,893
189,963
174,485
143,682
143,682174,485189,963118,89392,870108,75997,875113,439105,740108,757114,760127,678144,938188,555144,592148,64684,961166,958192,346216,596253,259158,729170,43766,03087,78761,20459,75374,00581,29587,31393,533100,537110,843121,181132,744134,87295,31694,47699,558106,585101,955101,00758,29267,70957,08247,28139,19741,55747,94161,830000
       Cash And Cash Equivalents 
3,584
0
0
61,824
20,954
25,470
15,751
11,126
10,096
28,245
13,880
22,640
18,889
13,244
22,391
20,557
33,901
30,125
35,172
19,831
24,870
15,147
39,564
37,274
32,349
28,179
27,583
51,270
82,176
64,215
168,692
130,727
129,867
91,525
113,080
103,320
43,514
135,061
125,328
170,470
67,782
35,514
24,972
24,314
100,256
46,687
63,950
78,166
74,933
97,260
183,086
94,986
78,835
78,83594,986183,08697,26074,93378,16663,95046,687100,25624,31424,97235,51467,782170,470125,328135,06143,514103,320113,08091,525129,867130,727168,69264,21582,17651,27027,58328,17932,34937,27439,56415,14724,87019,83135,17230,12533,90120,55722,39113,24418,88922,64013,88028,24510,09611,12615,75125,47020,95461,824003,584
       Short-term Investments 
0
0
0
0
26,857
15,597
22,937
35,726
46,480
38,478
43,571
77,290
82,423
92,398
76,204
72,809
58,774
101,946
96,921
100,636
85,388
84,388
53,302
49,608
48,548
44,392
30,335
8,994
4,496
4,496
161
14,912
119,786
120,134
74,173
56,908
31,992
31,992
0
0
73,444
85,583
83,163
79,102
79,004
59,591
30,357
25,810
12,961
13,944
0
70,677
59,220
59,22070,677013,94412,96125,81030,35759,59179,00479,10283,16385,58373,4440031,99231,99256,90874,173120,134119,78614,9121614,4964,4968,99430,33544,39248,54849,60853,30284,38885,388100,63696,921101,94658,77472,80976,20492,39882,42377,29043,57138,47846,48035,72622,93715,59726,8570000
       Net Receivables 
0
0
0
0
0
0
133
0
161
161
0
0
123
123
0
0
2,348
2,348
0
0
154
154
0
0
204
204
0
0
0
0
0
10,562
306
558
1,389
2,203
2,524
3,326
1,500
5,685
239
1,125
476
105
516
2,644
131
74
31
62
2
42
42
424226231741312,6445161054761,1252395,6851,5003,3262,5242,2031,38955830610,5620000020420400154154002,3482,34800123123001611610133000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131
327
306
294
478
3,096
4,372
6,316
9,367
0
0
0
0
-100,772
0
0
0
0
-62
0
-42
0
0-420-620000-100,77200009,3676,3164,3723,0964782943063271310000000000000000000000000000000
   > Long-term Assets 
0
0
0
937
11,096
69,148
66,467
51,549
35,841
18,532
21,669
31,422
23,306
9,141
7,784
3,407
3,333
7,131
2,952
2,485
2,251
2,027
1,890
1,731
2,334
2,244
2,086
1,935
2,004
2,381
2,481
24,426
23,977
26,769
26,195
25,642
60,085
59,508
53,940
29,215
9,411
9,223
9,130
3,120
2,922
2,709
2,534
2,336
2,180
1,984
1,795
1,668
6,036
6,0361,6681,7951,9842,1802,3362,5342,7092,9223,1209,1309,2239,41129,21553,94059,50860,08525,64226,19526,76923,97724,4262,4812,3812,0041,9352,0862,2442,3341,7311,8902,0272,2512,4852,9527,1313,3333,4077,7849,14123,30631,42221,66918,53235,84151,54966,46769,14811,096937000
       Property Plant Equipment 
8
0
0
719
709
793
782
884
811
755
730
674
631
577
1,489
2,885
2,825
2,645
2,456
2,282
2,048
1,865
1,728
1,569
1,417
1,271
1,127
989
861
1,003
1,270
1,210
1,369
4,559
4,374
4,187
4,024
3,861
3,700
3,317
3,142
2,963
2,794
2,656
210
2,363
2,209
2,048
1,881
1,707
1,534
1,371
1,208
1,2081,3711,5341,7071,8812,0482,2092,3632102,6562,7942,9633,1423,3173,7003,8614,0244,1874,3744,5591,3691,2101,2701,0038619891,1271,2711,4171,5691,7281,8652,0482,2822,4562,6452,8252,8851,489577631674730755811884782793709719008
       Long Term Investments 
0
0
0
0
0
68,269
65,599
50,579
34,944
17,691
20,558
30,340
22,344
8,234
5,757
0
0
4,001
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,995
5,998
5,992
0
0
0
0
0
0
0
0
0
0
00000000005,9925,9985,99500000000000000000000004,001005,7578,23422,34430,34020,55817,69134,94450,57965,59968,26900000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,969
21,577
21,185
20,793
20,400
20,008
19,616
19,223
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000019,22319,61620,00820,40020,79321,18521,57721,9690000000000000000000000000000000
       Other Assets 
0
0
0
218
10,387
68,355
65,685
50,665
35,030
17,777
20,939
30,748
22,675
8,564
6,295
522
508
4,486
496
203
203
162
162
162
917
973
959
946
1,143
1,378
1,211
1,247
1,031
1,025
1,028
1,055
36,053
36,031
31,017
25,898
8,995
262
344
464
410
346
325
288
299
0
261
0
0
0026102992883253464104643442628,99525,89831,01736,03136,0531,0551,0281,0251,0311,2471,2111,3781,1439469599739171621621622032034964,4865085226,2958,56422,67530,74820,93917,77735,03050,66565,68568,35510,387218000
> Total Liabilities 
368
0
0
2,125
71,803
3,030
3,295
3,218
2,457
3,410
5,270
5,724
7,815
6,401
8,163
9,072
9,883
10,098
10,435
11,423
10,625
6,596
6,355
6,608
11,332
15,777
13,607
22,154
32,107
29,859
46,051
75,542
152,937
154,905
169,234
171,083
137,872
85,171
84,159
87,997
39,075
34,292
35,685
16,222
21,103
43,377
46,517
48,222
47,659
66,693
69,008
71,814
71,185
71,18571,81469,00866,69347,65948,22246,51743,37721,10316,22235,68534,29239,07587,99784,15985,171137,872171,083169,234154,905152,93775,54246,05129,85932,10722,15413,60715,77711,3326,6086,3556,59610,62511,42310,43510,0989,8839,0728,1636,4017,8155,7245,2703,4102,4573,2183,2953,03071,8032,12500368
   > Total Current Liabilities 
368
0
0
2,008
3,146
2,937
3,213
3,149
2,399
3,364
5,238
5,706
7,804
6,392
7,871
8,385
9,204
9,461
9,837
10,864
10,109
6,124
5,925
6,220
10,991
13,233
11,066
19,618
17,128
14,845
22,132
53,441
37,077
28,624
31,204
30,510
29,890
25,728
28,784
37,678
17,093
11,844
12,744
13,536
18,590
16,886
20,092
21,873
21,663
22,359
20,787
23,812
26,380
26,38023,81220,78722,35921,66321,87320,09216,88618,59013,53612,74411,84417,09337,67828,78425,72829,89030,51031,20428,62437,07753,44122,13214,84517,12819,61811,06613,23310,9916,2205,9256,12410,10910,8649,8379,4619,2048,3857,8716,3927,8045,7065,2383,3642,3993,1493,2132,9373,1462,00800368
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
1,384
3,528
5,716
203
294
379
420
485
5,094
9,833
558
583
610
638
667
696
728
761
1,069
2,115
1,734
1,345
941
9411,3451,7342,1151,0697617286966676386105835589,8335,0944854203792942035,7163,5281,38414,91314,8282,3352,2932,2490000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
1,384
3,528
5,716
203
0
0
0
0
4,586
9,300
0
0
0
0
0
0
0
0
275
1,286
869
443
0
04438691,286275000000009,3004,58600002035,7163,5281,38414,91314,8282,3352,2932,2490000000000000000000000000
       Accounts payable 
279
0
0
1,246
2,273
1,936
2,450
1,737
1,848
1,926
2,034
1,836
2,760
2,515
3,159
3,299
3,216
3,951
2,999
3,646
3,942
2,595
2,149
1,962
4,095
8,809
6,825
7,363
9,186
7,267
8,514
11,249
10,253
8,593
11,538
8,842
9,655
7,233
2,241
4,681
1,875
2,453
1,395
641
2,302
2,896
1,706
5,359
4,901
4,903
4,553
5,118
7,184
7,1845,1184,5534,9034,9015,3591,7062,8962,3026411,3952,4531,8754,6812,2417,2339,6558,84211,5388,59310,25311,2498,5147,2679,1867,3636,8258,8094,0951,9622,1492,5953,9423,6462,9993,9513,2163,2993,1592,5152,7601,8362,0341,9261,8481,7372,4501,9362,2731,24600279
       Other Current Liabilities 
89
0
0
762
873
1,001
763
1,412
551
1,438
3,204
3,870
5,044
3,877
4,712
5,086
5,988
5,510
6,838
7,218
6,167
3,529
3,776
4,258
6,896
4,424
4,241
12,255
7,942
7,578
12,234
38,664
21,108
19,828
19,372
21,289
450
18,010
21,449
23,164
14,660
8,808
10,739
12,257
15,621
13,294
17,658
14,788
14,983
13,938
15,369
17,792
17,928
17,92817,79215,36913,93814,98314,78817,65813,29415,62112,25710,7398,80814,66023,16421,44918,01045021,28919,37219,82821,10838,66412,2347,5787,94212,2554,2414,4246,8964,2583,7763,5296,1677,2186,8385,5105,9885,0864,7123,8775,0443,8703,2041,4385511,4127631,0018737620089
   > Long-term Liabilities 
0
0
0
117
68,657
93
82
69
58
46
32
18
11
9
292
687
679
637
598
559
516
472
430
388
341
2,544
2,541
2,536
14,979
15,014
23,919
22,101
115,860
126,281
138,030
140,573
107,982
59,443
55,375
50,319
21,982
22,448
22,941
2,686
2,513
26,491
26,425
26,349
25,996
44,334
48,221
48,002
44,805
44,80548,00248,22144,33425,99626,34926,42526,4912,5132,68622,94122,44821,98250,31955,37559,443107,982140,573138,030126,281115,86022,10123,91915,01414,9792,5362,5412,5443413884304725165595986376796872929111832465869829368,657117000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249
2,293
2,335
14,828
14,913
23,520
21,535
114,737
121,973
133,836
136,131
103,623
55,214
51,280
47,238
19,051
19,672
20,326
243
249
24,412
24,538
24,667
24,526
39,574
39,739
0
0
0039,73939,57424,52624,66724,53824,41224924320,32619,67219,05147,23851,28055,214103,623136,131133,836121,973114,73721,53523,52014,91314,8282,3352,2932,2490000000000000000000000000
       Other Liabilities 
0
0
0
117
516
93
82
69
58
46
32
18
11
9
292
687
679
637
598
559
516
472
430
388
341
295
248
201
151
101
399
566
1,123
500
500
870
870
870
870
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000008708708708705005001,12356639910115120124829534138843047251655959863767968729291118324658698293516117000
       Deferred Long Term Liability 
0
0
0
0
0
66
57
47
38
28
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000016283847576600000
> Total Stockholder Equity
3,236
0
0
60,642
-12,766
107,675
102,369
95,612
90,466
82,831
74,691
126,705
117,446
109,325
99,179
88,811
88,766
131,905
125,261
112,243
102,469
95,968
89,068
82,436
72,297
60,472
48,232
40,985
57,684
38,552
126,867
107,613
124,299
88,460
49,307
21,517
7,174
122,983
114,373
129,773
115,274
102,609
88,205
95,655
87,559
72,771
53,892
62,873
47,391
54,184
122,750
104,339
78,533
78,533104,339122,75054,18447,39162,87353,89272,77187,55995,65588,205102,609115,274129,773114,373122,9837,17421,51749,30788,460124,299107,613126,86738,55257,68440,98548,23260,47272,29782,43689,06895,968102,469112,243125,261131,90588,76688,81199,179109,325117,446126,70574,69182,83190,46695,612102,369107,675-12,76660,642003,236
   Common Stock
1
0
0
1
1
2
2
2
2
2
2
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
5
5
7
7
7
7
7
7
8
16
17
17
17
17
17
18
19
19
19
21
20
20
3
3
3
333202021191919181717171717168777777554444444444433333322222211001
   Retained Earnings Total Equity00-777,518-753,237-737,523-720,715-702,625-680,673-663,711-647,230-624,444-607,542-592,511-572,647-585,785-562,800-524,785-486,011-455,872-413,678-375,576-364,227-342,559-324,192-303,142-284,907-261,781-248,345-235,323-223,668-215,746-207,177-198,883-187,020-171,575-156,198-141,018-127,069-113,736-100,715-87,653-76,329-65,738-55,488-46,451-38,530-28,163-21,33800000
   Accumulated Other Comprehensive Income 
0
0
0
-8,462
-14,469
-21,383
-28,174
-38,508
22
18
-3
80
28
22
29
26
11
39
32
44
43
135
77
60
29
12
-5
2
-2
-2,755
4
2
127
110
86
27
14
9
0
0
53
34
39
27
34
-113
-130
-39
0
6
1
49
13
1349160-39-130-113342739345300914278611012724-2,755-22-51229607713543443239112629222880-31822-38,508-28,174-21,383-14,469-8,462000
   Capital Surplus 
0
0
0
0
0
129,056
130,541
134,118
136,893
138,299
140,430
202,951
205,068
210,015
212,883
215,851
229,770
288,060
296,800
299,215
301,305
303,006
304,733
306,040
307,587
308,801
310,014
325,886
360,823
362,739
469,415
471,831
499,741
502,021
505,086
507,494
531,937
685,733
700,141
702,403
707,715
710,100
712,593
742,840
751,217
753,538
756,628
783,606
784,894
786,236
879,105
0
0
00879,105786,236784,894783,606756,628753,538751,217742,840712,593710,100707,715702,403700,141685,733531,937507,494505,086502,021499,741471,831469,415362,739360,823325,886310,014308,801307,587306,040304,733303,006301,305299,215296,800288,060229,770215,851212,883210,015205,068202,951140,430138,299136,893134,118130,541129,05600000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
69,103
-51,972
39,689
53,040
73,818
43,970
52,058
60,469
202,951
205,068
210,015
212,883
215,851
229,770
288,060
296,800
299,215
301,305
303,006
304,733
306,040
307,587
308,801
310,014
325,886
360,823
362,739
469,415
471,831
499,741
502,021
505,086
507,494
531,937
685,733
700,141
702,403
115,204
710,100
712,593
742,840
751,217
753,538
756,628
783,606
784,894
786,236
879,105
880,650
882,248
882,248880,650879,105786,236784,894783,606756,628753,538751,217742,840712,593710,100115,204702,403700,141685,733531,937507,494505,086502,021499,741471,831469,415362,739360,823325,886310,014308,801307,587306,040304,733303,006301,305299,215296,800288,060229,770215,851212,883210,015205,068202,95160,46952,05843,97073,81853,04039,689-51,97269,103000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-62
Gross Profit-62-62
 
Operating Income (+$)
Gross Profit-62
Operating Expense-92,022
Operating Income-92,084-92,084
 
Operating Expense (+$)
Research Development61,356
Selling General Administrative28,197
Selling And Marketing Expenses0
Operating Expense92,02289,553
 
Net Interest Income (+$)
Interest Income5,114
Interest Expense-4,139
Other Finance Cost-396
Net Interest Income1,371
 
Pretax Income (+$)
Operating Income-92,084
Net Interest Income1,371
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-87,367-96,801
EBIT - interestExpense = -96,223
-87,367
-83,228
Interest Expense4,139
Earnings Before Interest and Taxes (EBIT)-92,084-83,228
Earnings Before Interest and Taxes (EBITDA)-92,022
 
After tax Income (+$)
Income Before Tax-87,367
Tax Provision-0
Net Income From Continuing Ops-76,807-87,367
Net Income-87,367
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses92,084
Total Other Income/Expenses Net4,717-1,371
 

Technical Analysis of Verastem
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Verastem. The general trend of Verastem is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Verastem's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Verastem Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.50 < 13.82 < 14.22.

The bearish price targets are: 10.30 > 9.81 > 9.78.

Tweet this
Verastem Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Verastem Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Verastem Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Verastem Inc. The current macd is -0.05622174.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Verastem price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Verastem. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Verastem price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Verastem Inc Daily Moving Average Convergence/Divergence (MACD) ChartVerastem Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Verastem Inc. The current adx is 18.77.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Verastem shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Verastem Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Verastem Inc. The current sar is 10.07.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Verastem Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Verastem Inc. The current rsi is 51.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Verastem Inc Daily Relative Strength Index (RSI) ChartVerastem Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Verastem Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Verastem price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Verastem Inc Daily Stochastic Oscillator ChartVerastem Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Verastem Inc. The current cci is 20.61.

Verastem Inc Daily Commodity Channel Index (CCI) ChartVerastem Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Verastem Inc. The current cmo is 5.40568283.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Verastem Inc Daily Chande Momentum Oscillator (CMO) ChartVerastem Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Verastem Inc. The current willr is -26.02230483.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Verastem is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Verastem Inc Daily Williams %R ChartVerastem Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Verastem Inc.

Verastem Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Verastem Inc. The current atr is 0.76639317.

Verastem Inc Daily Average True Range (ATR) ChartVerastem Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Verastem Inc. The current obv is 12,664,722.

Verastem Inc Daily On-Balance Volume (OBV) ChartVerastem Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Verastem Inc. The current mfi is 67.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Verastem Inc Daily Money Flow Index (MFI) ChartVerastem Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Verastem Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Verastem Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Verastem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.204
Ma 20Greater thanMa 5011.656
Ma 50Greater thanMa 10011.958
Ma 100Greater thanMa 2009.826
OpenGreater thanClose11.790
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Verastem with someone you think should read this too:
  • Are you bullish or bearish on Verastem? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Verastem? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Verastem Inc

I send you an email if I find something interesting about Verastem Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Verastem Inc.

Receive notifications about Verastem Inc in your mailbox!